Диссертация (1154761), страница 15
Текст из файла (страница 15)
E. et al. The Churg-Strauss Syndrome // J. Am Soc. Nephrol. 1999.Vol. 10. Р. 2048–2055.14. Grayson P.C. et al. Value of commonly measured laboratory tests asbiomarkers of disease activity and predictors of relapse in eosinophilic granulomatosiswith polyangiitis // Rheumatology. Nov 17 2014 [Epub ahead of print].15. Наместникова О.Г., Кривошеев О.Г. Синдром Черга–Страусс // MedicusAmicus.
2007. Vol. 1. С. 16–27.16. МоисеевС.В.ссоавт.Клиническиеаспектысиндромагиперэозинофилии // Клиническая медицина. 2004. № 2. С. 28-31.17. Zwerina J. et al. Eotaxin-3 in Churg-Strauss syndrome: a clinical andimmunogenetic study // Rheumatology (Oxford). 2011. Vol. 50.
№ 10. Р. 1823–27.18. Goronzy, J.J., Weyand С.М. Cytokines in giant-cell arteritis // Cleve Clin JMed. 2002. 69 Suppl 2: p. SII91-4.19. Фомин В.В. с соавт. Артериит Хортона как причина лихорадки неясногогенеза у пожилого больного// Фарматека. 2012. № 14. С.
9-13.20. Мухин Н.А. с соавт. Артериит Такаясу: трудности диагностики, лечениеи исходы в когортном исследовании у 128 больных // Клиническая фармакологияи терапия. 2014. М.: Фарма Пресс. Т. 23. № 3. С. 55-61.21. Семенкова Е.Н. Диагноз и дифференциальный диагноз головной болипри гигантоклеточном артериите // Врач.
2006. № 5. С.82-83.22. Lanham J. et al. Systemic vasculitis with asthma and eosinophilia: a clinicalapproach to the Churg Strauss syndrome // Medicine (Baltimore). 1984. Vol. 63. Р. 65–81.9023. Masi A. et al. The American College of Rheumatology 1990 criteria for theclassification of Churg-Strauss syndrome (allergic granulomatosis and angiitis) //Arthritis Rheum. 1990.
Vol. 33. № 8. Р. 1094–100.24. Mukhtyar C. et al. EULAR recommendations for the management of primarysmall and medium vessel vasculitis // Ann Rheum Dis. 2009. Vol. 68. № 3. Р. 310–7.25. ТареевЕ.М.,СеменковаЕ.Н.Астматическийвариант узелкового периартериита // Клин. Медицина. 1969. № 7. С. 28-34.26. Churg A. Recent advances in the diagnosis of Churg–Strauss syndrome //Mod Pathol.
2001. Vol. 14. Р. 1284–93.27. Guillevin L. et al. Churg–Strauss syndrome: clinical study and long-termfollow-up of 96 patients // Medicine. 1999. Vol. 78. Р. 26–37.28. Sable-Fourtassou R. et al. Antineutrophil cytoplasmic antibodies and theChurg–Strauss syndrome // Ann Intern Med. 2005. Vol. 143. Р. 632–8.29. Kahn J.E.
et al.Hypereosinophilic syndromes // Best Pract Res ClinRheumatol. 2008. Vol. 22. Р. 863–82.30. Abril A., Calamia K.T., Cohen MD. The Churg-Strauss syndrome (allergicgranulomatous angiitis): review and update // Semin Arthritis Rheum. 2003. Vol. 33. Р.106–14.31. Guillevin L., Ronco P., Verroust P. Circulating immune complexes insystemic necrotising vasculitis of the polyarteritis nodosa group. Comparison of HBVrelated polyarteritis nodosa and Churg-Strauss angiitis // J.
Autoimmun. 1990. Vol. 3. Р.789–92.32. Guillevin L. et al. Systemic necrotising vasculitis with asthma: causes andprecipitating factors in 43 cases // Lung. 1987. P. 165–72.33. Davies D. et al. Segmental necrotising glomerulonephritis with antineutrophilantibody: possible arbovirus etiology // BMJ. 1982. Vol. 285. Р. 606.9134. Van Der Woude F. et al. Antibodies against neutrophils and monocytes: toolfor diagnosis and marker of disease activity in Wegener’s granulomatosis // Lancet.1985. 1 (8426).
Р. 425–29.35. Falk R., Jenette J. Anti-neutrophil cytoplasmic antibodies with specificity formyeloperoxidase in patients with systemic vasculitis and idiopathic necrotising andcresenteric glomerulonephritis // N. Engl. J. Med.
1988. Vol. 318. Р. 1651–57.36. Falk R. et al. Antineutrophil cytoplasmic antibodies induce neutrophils todegranulate and produce oxygen radicals in vitro // Proc. Natl. Acad. Sci USA. 1990.Vol. 87. Р. 4115–19.37. Charles L. et al. Antibodies against granule proteins activate neutrophils invitro // J. Leukocyte Biol. 1991. Vol.
50. Р. 539–46.38. Savage C. et al. Antineutrophil cytoplasmic antibodies can recognise vascularendothelial bound antineutrophil-cytoplasm associated autoantigens // Exp. Nephrol.1993. Vol. 1. Р. 190–95.39. Berger S. et al. Proteinase-3, the major autoantigen in Wegener’sgranulomatosis, enhances IL-8 production by endothelial cells in vitro // J. Am. Soc.Nephrol. 1996. Vol. 7. Р. 694–701.40.
Абайтова Н.Е. с соавт. Антитела к протеиназе-3 и миелопероксидазе присистемных васкулитах // Терапевтический архив. 2004. № 5. С. 22-28.41. Wechsler M. et al. Pulmonary infiltrates, eosinophilia and cardiomyopathyfollowing corticosteroid withdrawal in patients with asthma receiving zafirlukast //JAMA.
1998. Vol. 279. Р. 455–57.42. Josefson D. Asthma drug linked with Churg-Strauss syndrome // BMJ. 1997.Vol. 315. Р. 350.43. Kinoshita M. et al. Churg-Strauss syndrome after corticosteroid withdrawal inan asthmatic patient treated with pranlukast // J. Allergy Clin. Immunol. 1999. Vol. 103.Р. 534–35.9244. Rosenwasser L.
Leukotreine modifiers: new drugs, old and new reactions // J.Allergy Clin. Immunol. 1999. Р. 374–75.45. Hubner C. et al. Macrolide-induced Churg– Strauss syndrome in a patientwith atopy //Lancet. 1997. Vol. 350. Р. 563.46. Jarzobski J. et al. Vasculitis with allopurinol therapy // Am Heart J. 1970.Vol. 79. Р. 116–21.47. Gaffey C. et al. Phenytoin induced systemic granulomatous vasculitis // Arch.Pathol.
Lab. Med. 1986. Vol. 110. Р. 131–35.48. Imai H. et al. Carbamazepine induced granulomatous necrotising angiitis withacute renal failure // Nephron. 1989. Vol. 51. Р. 405–08.49. Park K., Chipps D., Benson E. Necrotizing vasculitis secondary topropylthiouracil presenting as purpura fulminans // Br. J. Rheumatol. 1999. Vol. 38.
Р.790–92.50. Tai P. et al. Deposition of eosinophil cationic protein in granulomas inallergic granulomatosis and vasculitis: the Churg-Strauss syndrome // Br. Med. J.(Clin.Res. Ed). 1984. Vol. 18. Р. 400–02.51. Terrier B. et al. Interleukin-25: a cytokine linking eosinophils and adaptiveimmunity in Churg–Strauss syndrome // Blood.
2010. Vol. 116. Р. 4523–31.52. Khoury P. et al. Serum biomarkers are similar in Churg-Strauss syndrome andhypereosinophilic syndrome // Allergy. 2012. Vol. 67. Р. 1149–56.53. Polzer K. et al. Eotaxin-3 is involved in Churg-Strauss syndrome-a serummarker closely correlating with disease activity // Rheumatology (Oxford). 2008. Vol.47. № 6. Р. 804–08.54. Ramentol-Sintas M., Martínez-Valle F., Solans-Laqué R.
Churg–StraussSyndrome: an 579 evolving paradigm //Autoimmun Rev. 2012. Vol. 12. Р. 235–40.55. Vaglio A. et al. IgG4 immune 626 response in Churg–Strauss syndrome //Ann. Rheum. Dis. 2012. Vol. 71. Р. 390–3.9356. Vaglio A. et al. HLADRB4 as a genetic risk factor for Churg–Strausssyndrome // Arthritis Rheum. 2007. Vol.
56. Р. 3159–66.57. Mahr A. et al. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss):evolution in classification, ethiopathogenesis, assessment and management // Curr.Opin. Rheumatol. 2014. Vol. 26. Р. 16–23.58. Wieczorek S. et al. Functionally relevant variations of the interleukin-10 geneassociated with antineutrophil cytoplasmic antibody-negative Churg–Strauss syndrome,but not with Wegener’s granulomatosis // Arthritis Rheum. 2008. Vol.
58. Р. 1839–48.59. Vaglio A. et al. Churg–Strauss syndrome // Kidney Int. 2009. Vol. 76. Р.1006–11.60. Neumann T. et al. Cardiac involvement in Churg-Strauss syndrome: impact ofendomyocarditis //Medicine (Baltimore). 2009. Vol. 88. № 4. Р. 236–43.61. НаместниковаО.Г.Особенностипрогностичеклиническоготечения,рга–Страусс.Дисс.
канд. мед. наук. М., 2009.62. Gross W. L. Das Churg-Strauss-Syndrom // Internist. 2001. Vol. 42. Р. 1583–1590.63. Noth I., Strek M., Leff A. Churg–Strauss syndrome // Lancet. 2003. Р. 587–94.64. Gupta S. et al. Qualitative analysis of high-resolution CT scans in severeasthma // Chest. 2009. Vol. 136. Р. 1521–8.65. Bacciu A. et al.
Nasal polyposis in Churg–Strauss syndrome // Laryngoscope.2008. Vol. 118. Р. 325–29.66. Keogh K., Specks U. Churg–Strauss syndrome // Semin. Respir. Crit. CareMed. 2006. Vol. 27. Р. 148–57.9467. Sinico R. et al. Prevalence and clinical significance of antineutrophilcytoplasmic antibodies in Churg–Strauss syndrome // Arthritis Rheum. 2005. Vol. 52.Р. 2926–35.68. Keogh K., Specks U. Churg–Strauss syndrome: clinical presentation,antineutrophil cytoplasmic antibodies, and leukotriene receptor antagonists // Am J.Med. 2003. Vol. 115.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
